# US 2026/0123649 A1 · Compositions and methods for nutraceutical gummy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0123649 A1
- Document ID: US20260123649A1
- Status: Published application
- Kind: A1
- Application number: 19/376,049
- Filed: 2025-10-31
- Published: 2026-05-07
- Earliest claimed: 2024-10-31
- Assignees: Noon World Inc.
- Applicants: Noon World Inc.
- Inventors: Julie Sok Lin Hwang; Jane Kate Wong; Christine Tse-Mun Wong
- Web page: https://patentgrep.com/patent/US20260123649A1

## CPC

- A23G 3/54: Composite products, e.g. layered, coated, filled
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23G 3/364: {containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins}
- A23G 3/368: {containing vitamins, antibiotics}
- A23G 3/42: characterised by the carbohydrates used, e.g. polysaccharides (containing dairy products A23G3/46)
- A23G 3/48: containing plants or parts thereof, e.g. fruits, seeds, extracts (containing gums A23G3/42)
- A23L 33/15: Vitamins
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 31/05: Phenols {(cannabinoids A61K31/658)}
- A61K 31/122: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K 31/197: the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid (carnitine A61K31/205)
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/4375: the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A61K 31/4415: Pyridoxine, i.e. Vitamin B6 (pyridoxal phosphate A61K31/675)
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61K 31/522: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A61K 31/593: 9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A61K 31/714: Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A61K 31/732: Pectin
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 36/068: Cordyceps
- A61K 36/07: Basidiomycota, e.g. Cryptococcus
- A61K 36/074: Ganoderma
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/258: Panax (ginseng)
- A61K 36/28: Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K 36/35: Caprifoliaceae (Honeysuckle family)
- A61K 36/41: Crassulaceae (Stonecrop family)
- A61K 36/68: Plantaginaceae (Plantain Family)
- A61K 36/79: Schisandraceae (Schisandra family)
- A61K 36/81: Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K 36/815: Lycium (desert-thorn)
- A61K 36/82: Theaceae (Tea family), e.g. camellia
- A61K 36/84: Valerianaceae (Valerian family), e.g. valerian
- A61K 36/88: Liliopsida (monocotyledons)
- A61K 36/9062: Alpinia, e.g. red ginger or galangal
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A23G: COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

A nutraceutical gummy includes a dual-layer configuration that has an inner core and, distinct from the inner core, a casing shell fully encasing the inner core. The inner core has a core composition including, by weight percentage, 55-85% of a syrup, 10-20% of water, 1-7% of stevia leaf extract, and 1-5% of pectin. The casing shell has a shell composition including, by weight percentage, 55-85% of a syrup, 10-20% of water, 1-7% of stevia leaf extract, and 1-5% of pectin.

## Claims

### Claim 1

A nutraceutical gummy comprising:
a dual-layer configuration including an inner core and, distinct from the inner core, a casing shell fully encasing the inner core, the inner core having a core composition including, by weight percentage, 55-85% of a syrup, 10-20% of water, 1-7% of stevia leaf extract, 1-5% of pectin, the casing shell having a shell composition including, by weight percentage, 55-85% of a syrup, 10-20% of water, 1-7% of stevia leaf extract, and 1-5% of pectin.

### Claim 2 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes 0.01-1% of L-malic acid, 0.01-1% of sodium citrate, 0.01-1% of natural flavors, 0.01-1% of natural colors, and 0.01-1% of carnauba wax, and the shell composition further includes 0.01-1% of L-malic acid, 0.01-1% of sodium citrate, 0.01-1% of carnauba wax, 0.01-1% of natural flavors, and 0-1% of natural colors.

### Claim 3 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes 0.1-1% of L-theanine.

### Claim 4 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes gamma-aminobutyric acid.

### Claim 5 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes gamma-aminobutyric acid and L-theanine, and a ratio, by weight, of the L-theanine to the gamma-aminobutyric acid is from 5:1 to 1:5 for relaxation or sleep.

### Claim 6 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes 0.1-3% of a constituent selected from the group consisting of Camellia sinensis, Hericium erinaceus, Cordyceps sinensis, Rhodiola rosea, Lycium barbarum, vitamin B6, vitamin B9, vitamin B12, vitamin D3, Ganodema lucidum extract, and combinations thereof.

### Claim 7 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes 0.1-1% of a constituent selected from the group consisting of Withania somnifera, Inonotus obliquus, Grifola frondosa, Coriolis versicolor, Lentinula edodes, Passiflora incarnata, Valeriana officinalis, Tremella fuciformis, Wolfporia extensa, Matricaria chamomilla, magnesium glycinate, caffeine, creatine, Alpinia galanga extract, Panax ginseng extract, Schisandra chinensis extract, theobromine, Crocus sativus (saffron) extract, magnesium L-theonate, Conenzyme Q10, N-acetylcysteine, berberine, Resveratrol, Pterostilbene, and combinations thereof.

### Claim 8 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes 0.1-1% Crocus sativus (Saffron) 0.1-1% Panax Ginseng, 0.1-1% Alpinia Galanga, and 0.1-1% Schisandra chinensis for energy.

### Claim 9 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes 0.5-1% of Camellia sinensis extract and 0.1-1% of L-theanine for focus and energy.

### Claim 10 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes 0.1-3% of Camellia sinensis and 0.1-1% of Cordyceps sinensis for energy and endurance.

### Claim 11 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes 0.1-1% of Cordyceps sinensis and 0.1-1% Rhodiola rosea for stamina.

### Claim 12 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes 0.1-1% of caffeine and 0.1-1% of L-theanine for focus and energy.

### Claim 13 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes 0.1-1% of caffeine and 0.1-1% theobromine for focus and energy.

### Claim 14 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes 0.1-1% of caffeine and 0.1-1% creatine for focus and energy.

### Claim 15 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes 0.1-1% of caffeine and 0.1-1% Alpinia galanga for energy.

### Claim 16 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further include 0.1-1% gamma-aminobutyric acid and 0.1-1% of Passiflora incarnata for relaxation and sleep, or 0.1-1% of Valeriana officinalis and 0.1-1% L-theanine for sleep.

### Claim 17 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes 0.1-1% of magnesium and 0.1-1% of L-theanine for relaxation or focus.

### Claim 18 (depends on 1)

The nutraceutical gummy as recited in claim 1, wherein the core composition further includes at least one of:
0.5-1% of Camellia sinensis and 0.1-1% of L-theanine,
0.1-3% of Camellia sinensis and 0.1-1% of Cordyceps sinensis,
0.1-1% of Cordyceps sinensis and 0.1-1% of Rhodiola rosea
0.1-1% of caffeine and 0.1-1% of L-theanine,
0.1-1% of caffeine and 0.1-1% of theobromine,
0.1-1% of caffeine and 0.1-1% of creatine,
0.1-1% of caffeine and 0.1-1% of Alpinia galanga,
0.1-1% of gamma-aminobutyric acid and 0.1-1% of L-theanine,
0.1-1% of gamma-aminobutyric acid and 0.1-1% of Passiflora incarnata,
0.1-1% of Valeriana officinalis and 0.1-1% of Passiflora incarnata,
0.1-1% of Valeriana officinalis and 0.1-1% of L-theanine, or
0.1-1% of magnesium and 0.1-1% of L-theanine.

### Claim 19

A method of administration of a nutraceutical gummy, the method comprising:
providing a serving of the nutraceutical gummy for oral ingestion, the nutraceutical gummy having a dual-layer configuration including an inner core and, distinct from the inner core, a casing shell fully encasing the inner core, the inner core having a core composition including, by weight percentage, 55-85% of a syrup, 10-20% of water, 1-7% of stevia leaf extract, 1-5% of pectin, the casing shell having a shell composition including, by weight percentage, 55-85% of a syrup, 10-20% of water, 1-7% of stevia leaf extract, and 1-5% of pectin.

### Claim 20 (depends on 19)

The method as recited in claim 19, wherein the oral ingestion includes mastication by chewing, at least a portion of the core composition absorbed through buccal and sublingual mucosa.
